ZVRA
ZEVRA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$11.61
−1.94%Forward multiples
Based on analyst estimates
- P/E forward
- 13.59x
- P/E 2026E
- 10.55x
- P/E 2027E
- 12.50x
- P/E 2028E
- 8.29x
- P/S forward
- 4.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.09x
- PEG TTM
- —
- Price / book
- 3.17x
- Price / sales
- 5.07x
- Price / cash flow
- 20.64x
Enterprise value
- Enterprise value
- $469.4M
- EV / sales
- 3.45x
- EV / EBITDA
- 6.43x
- EV / EBIT
- 12.01x
- Market cap
- $689.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026